Neuropsychological assessment as an objective tool to monitor treatment response in anti-N-methyl-D-aspartate receptor encephalitis

Erica Sieg, Michael Brook, Jenny Linnoila, Stephen Vanhaerents*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

We report a 1-year follow-up of a young woman with anti-N-methyl-D-aspartate receptor encephalitis. Management of autoimmune encephalitis remains challenging as objective and clinically relevant biomarkers are sought, which allow for the monitoring of treatment response. While further investigation is required, we believe that this case highlights the importance of following a comprehensive neuropsychological profile as a clinically relevant biomarker to guide therapeutic decision-making. By relying on the neuropsychological assessment of the patient, treatment with more toxic medications was avoided and her antiepileptic drug regimen was simplified.

Original languageEnglish (US)
Article numberbcr-2018-224169
JournalBMJ Case Reports
Volume2018
DOIs
StatePublished - Jan 1 2018

Keywords

  • clinical neurophysiology
  • epilepsy and seizures
  • immunology
  • memory disorders (psychiatry)

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Neuropsychological assessment as an objective tool to monitor treatment response in anti-N-methyl-D-aspartate receptor encephalitis'. Together they form a unique fingerprint.

  • Cite this